Balgopal Commer. (539834)

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Book value of ₹21.71 provides some per-share asset backing, even though price is above it.
• ROCE of 14.42% suggests the operating capital base is earning a positive return.
• Piotroski F-Score of 6/9 indicates moderately healthy financials, not deeply distressed.
• Latest quarter net profit of ₹1 Cr shows some residual earning power despite zero sales.

Concerns

• Sales growth of -88.89% and latest quarterly sales of ₹0 Cr mean the core business has effectively stopped generating revenue.
• ROE of -5.75% with P/B of 1.84 means investors pay a premium to book while equity returns are negative.
• P/E of 0.00 and zero dividend offer no earnings support or income return.
• Current price of ₹39.87 versus the stated 52-week range of ₹130-272.95 signals severe price dislocation or data inconsistency, a red flag for liquidity and credibility.

AI Analysis

This is not the kind of business I would normally spend a minute on. Balgopal Commer is a tiny trading and distribution company with a market cap of just ₹66 crore. Its sales have collapsed by 88.89%, and the latest quarter shows zero revenue. When a distributor has no sales, it has no function. The single crore of net profit in the quarter is meaningless compared with the destruction of the top line. Graham taught me to buy with a margin of safety. Here the P/E ratio is zero, which is not a sign of cheapness but of earnings that are either negligible or negative. The ROE is -5.75%, so the business is currently destroying shareholder equity. The ROCE of 14.42% sounds respectable, but a positive operating return on capital combined with a negative return on equity tells me that non-operating or financial items are eating away at net income. I cannot rely on such numbers. The price of ₹39.87 is 1.84 times book value of ₹21.71. That means the market is asking me to pay a premium to book for a business whose equity returns are negative. There is no dividend. The 52-week range of ₹130-272.95 also seems to be disconnected from the current price—another warning that this is a speculative and possibly illiquid stock. Piotroski F-Score of 6/9 is mediocre, not compelling. I look for companies that earn high returns on tangible capital, generate cash, and have a durable moat. Balgopal has none of those traits. It may be a turnaround candidate if management can rebuild sales and earn real profits, but that is hope, not investment. At best, this is a very small, early-stage speculative turnaround. I would need evidence of revenue revival, consistent profits, and honest capital allocation before I would even consider it.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer